Research article summary (published 18 Aug 2009):

Editorial comment.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Yang, Stephen Shei-Dei (SS);

Journal and publication information

Publication Type: Comment; Editorial

Journal: The Journal of urology (J Urol), published in United States. (Language: eng)

Reference: 2009-Oct; vol 182 (issue 4 Suppl) : pp 2038-9; discussion 2039

Dates: Created 2009/09/14; Completed 2009/10/29;

PMID: 19695625, status: MEDLINE (last retrieval date: 10/29/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: J Urol. 2009 Oct;182(4 Suppl):2033-8. (PMID: 19695628)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Benzhydryl Compounds - therapeutic use Child Cresols - therapeutic use Drug Therapy, Combination Humans

Humans Mandelic Acids - therapeutic use Muscarinic Antagonists - therapeutic use Phenylpropanolamine - therapeutic use Urinary Bladder, Overactive - drug therapy

Associated Chemicals: Benzhydryl Compounds (0) ; Cresols (0) ; Mandelic Acids (0) ; Muscarinic Antagonists (0) ; tolterodine (124937-51-5) ; Phenylpropanolamine (14838-15-4) ; oxybutynin (5633-20-5)

Related articles

These are the highest related articles currently in the database:

• Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. 30 Mar 2008
• Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin. 29 Nov 2006
• Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder. 30 Jul 2007
• The effects of reformulation: improved therapeutic index. 30 Oct 2008
• Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials. 31 Mar 2007
• A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. 7 Jul 2008
• Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder. 18 Oct 2006
• Tolterodine for treatment of overactive bladder. 30 Oct 2006
• Satisfaction with tolterodine: assessing symptom-specific patient-reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study). 5 Dec 2007
• Efficacy of tolterodine in women with detrusor overactivity and anterior vaginal wall prolapse: is it the same? 15 Sep 2007

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.